#Table 1
table1(~Gender_Legal_Sex+age_10year+htn+dm+cad+chf+copd+nsaid+beta_blockers+statins+ace_arb+ppi+diur+immunosuppressant+vaccine_ACTUAL+renal_group2+cancer+pre_cre_freq_cat+pre_inpt_freq_cat+new_renal_outcome_status+new_dm_outcome_status+new_cv_outcome_status+sglt2i+ccb+statins+
pre_HGB_365days_cat+pre_ALB_365days_cat+pre_WBC_365days_cat+pre_sodium_365days_cat+pre_potassium_365days_cat+pre_urine_proetein_ratio_365days_cat|case,data=matched_final)| 0 (N=840) |
1 (N=840) |
Overall (N=1680) |
|
|---|---|---|---|
| Gender_Legal_Sex | |||
| Female | 450 (53.6%) | 430 (51.2%) | 880 (52.4%) |
| Male | 390 (46.4%) | 410 (48.8%) | 800 (47.6%) |
| age_10year | |||
| Mean (SD) | 7.34 (1.33) | 7.32 (1.33) | 7.33 (1.33) |
| Median [Min, Max] | 7.50 [2.15, 10.0] | 7.50 [2.18, 10.4] | 7.50 [2.15, 10.4] |
| htn | |||
| 0 | 130 (15.5%) | 128 (15.2%) | 258 (15.4%) |
| 1 | 710 (84.5%) | 712 (84.8%) | 1422 (84.6%) |
| dm | |||
| 0 | 446 (53.1%) | 432 (51.4%) | 878 (52.3%) |
| 1 | 394 (46.9%) | 408 (48.6%) | 802 (47.7%) |
| cad | |||
| 0 | 383 (45.6%) | 407 (48.5%) | 790 (47.0%) |
| 1 | 457 (54.4%) | 433 (51.5%) | 890 (53.0%) |
| chf | |||
| 0 | 751 (89.4%) | 752 (89.5%) | 1503 (89.5%) |
| 1 | 89 (10.6%) | 88 (10.5%) | 177 (10.5%) |
| copd | |||
| 0 | 689 (82.0%) | 697 (83.0%) | 1386 (82.5%) |
| 1 | 151 (18.0%) | 143 (17.0%) | 294 (17.5%) |
| nsaid | |||
| 0 | 673 (80.1%) | 675 (80.4%) | 1348 (80.2%) |
| 1 | 167 (19.9%) | 165 (19.6%) | 332 (19.8%) |
| beta_blockers | |||
| 0 | 495 (58.9%) | 483 (57.5%) | 978 (58.2%) |
| 1 | 345 (41.1%) | 357 (42.5%) | 702 (41.8%) |
| statins | |||
| 0 | 424 (50.5%) | 420 (50.0%) | 844 (50.2%) |
| 1 | 416 (49.5%) | 420 (50.0%) | 836 (49.8%) |
| ace_arb | |||
| 0 | 515 (61.3%) | 498 (59.3%) | 1013 (60.3%) |
| 1 | 325 (38.7%) | 342 (40.7%) | 667 (39.7%) |
| ppi | |||
| 0 | 568 (67.6%) | 568 (67.6%) | 1136 (67.6%) |
| 1 | 272 (32.4%) | 272 (32.4%) | 544 (32.4%) |
| diur | |||
| 0 | 530 (63.1%) | 524 (62.4%) | 1054 (62.7%) |
| 1 | 310 (36.9%) | 316 (37.6%) | 626 (37.3%) |
| immunosuppressant | |||
| 0 | 792 (94.3%) | 796 (94.8%) | 1588 (94.5%) |
| 1 | 48 (5.7%) | 44 (5.2%) | 92 (5.5%) |
| vaccine_ACTUAL | |||
| 0 | 126 (15.0%) | 113 (13.5%) | 239 (14.2%) |
| 1 | 714 (85.0%) | 727 (86.5%) | 1441 (85.8%) |
| renal_group2 | |||
| eGFR <30, no ESKD | 58 (6.9%) | 54 (6.4%) | 112 (6.7%) |
| eGFR 30-44.9, no ESKD | 177 (21.1%) | 194 (23.1%) | 371 (22.1%) |
| eGFR 45-59.9, no ESKD | 506 (60.2%) | 498 (59.3%) | 1004 (59.8%) |
| ESKD | 99 (11.8%) | 94 (11.2%) | 193 (11.5%) |
| cancer | |||
| 0 | 473 (56.3%) | 486 (57.9%) | 959 (57.1%) |
| 1 | 367 (43.7%) | 354 (42.1%) | 721 (42.9%) |
| pre_cre_freq_cat | |||
| 1 | 181 (21.5%) | 176 (21.0%) | 357 (21.3%) |
| 2-4 | 659 (78.5%) | 664 (79.0%) | 1323 (78.8%) |
| pre_inpt_freq_cat | |||
| 0 | 617 (73.5%) | 621 (73.9%) | 1238 (73.7%) |
| 1-2 | 124 (14.8%) | 118 (14.0%) | 242 (14.4%) |
| 3+ | 99 (11.8%) | 101 (12.0%) | 200 (11.9%) |
| new_renal_outcome_status | |||
| Mean (SD) | 0.0595 (0.237) | 0.0345 (0.183) | 0.0470 (0.212) |
| Median [Min, Max] | 0 [0, 1.00] | 0 [0, 1.00] | 0 [0, 1.00] |
| new_dm_outcome_status | |||
| Mean (SD) | 0.0310 (0.173) | 0.0202 (0.141) | 0.0256 (0.158) |
| Median [Min, Max] | 0 [0, 1.00] | 0 [0, 1.00] | 0 [0, 1.00] |
| new_cv_outcome_status | |||
| Mean (SD) | 0.183 (0.387) | 0.181 (0.385) | 0.182 (0.386) |
| Median [Min, Max] | 0 [0, 1.00] | 0 [0, 1.00] | 0 [0, 1.00] |
| sglt2i | |||
| 0 | 801 (95.4%) | 791 (94.2%) | 1592 (94.8%) |
| 1 | 39 (4.6%) | 49 (5.8%) | 88 (5.2%) |
| ccb | |||
| 0 | 582 (69.3%) | 580 (69.0%) | 1162 (69.2%) |
| 1 | 258 (30.7%) | 260 (31.0%) | 518 (30.8%) |
| pre_HGB_365days_cat | |||
| Missing | 40 (4.8%) | 82 (9.8%) | 122 (7.3%) |
| Q1 | 200 (23.8%) | 192 (22.9%) | 392 (23.3%) |
| Q2 | 204 (24.3%) | 187 (22.3%) | 391 (23.3%) |
| Q3 | 174 (20.7%) | 189 (22.5%) | 363 (21.6%) |
| Q4 | 222 (26.4%) | 190 (22.6%) | 412 (24.5%) |
| pre_ALB_365days_cat | |||
| Missing | 136 (16.2%) | 119 (14.2%) | 255 (15.2%) |
| Q1 | 162 (19.3%) | 261 (31.1%) | 423 (25.2%) |
| Q2 | 179 (21.3%) | 154 (18.3%) | 333 (19.8%) |
| Q3 | 212 (25.2%) | 183 (21.8%) | 395 (23.5%) |
| Q4 | 151 (18.0%) | 123 (14.6%) | 274 (16.3%) |
| pre_WBC_365days_cat | |||
| Missing | 40 (4.8%) | 82 (9.8%) | 122 (7.3%) |
| Q1 | 191 (22.7%) | 233 (27.7%) | 424 (25.2%) |
| Q2 | 189 (22.5%) | 166 (19.8%) | 355 (21.1%) |
| Q3 | 209 (24.9%) | 167 (19.9%) | 376 (22.4%) |
| Q4 | 211 (25.1%) | 192 (22.9%) | 403 (24.0%) |
| pre_sodium_365days_cat | |||
| Missing | 7 (0.8%) | 5 (0.6%) | 12 (0.7%) |
| Q1 | 237 (28.2%) | 293 (34.9%) | 530 (31.5%) |
| Q2 | 211 (25.1%) | 197 (23.5%) | 408 (24.3%) |
| Q3 | 221 (26.3%) | 205 (24.4%) | 426 (25.4%) |
| Q4 | 164 (19.5%) | 140 (16.7%) | 304 (18.1%) |
| pre_potassium_365days_cat | |||
| Missing | 12 (1.4%) | 15 (1.8%) | 27 (1.6%) |
| Q1 | 224 (26.7%) | 234 (27.9%) | 458 (27.3%) |
| Q2 | 204 (24.3%) | 196 (23.3%) | 400 (23.8%) |
| Q3 | 198 (23.6%) | 209 (24.9%) | 407 (24.2%) |
| Q4 | 202 (24.0%) | 186 (22.1%) | 388 (23.1%) |
| pre_urine_proetein_ratio_365days_cat | |||
| <=0.1 | 14 (1.7%) | 4 (0.5%) | 18 (1.1%) |
| >0.1 | 30 (3.6%) | 19 (2.3%) | 49 (2.9%) |
| Not checked | 796 (94.8%) | 817 (97.3%) | 1613 (96.0%) |
#Table 1.2
table1(~Gender_Legal_Sex+age_10year+htn+dm+cad+chf+copd+nsaid+beta_blockers+statins+ace_arb+ppi+diur+immunosuppressant+vaccine_ACTUAL+renal_group2+cancer+pre_cre_freq_cat+pre_inpt_freq_cat+new_renal_outcome_status+new_dm_outcome_status+new_cv_outcome_status+sglt2i+ccb+statins+
pre_HGB_365days_cat+pre_ALB_365days_cat+pre_WBC_365days_cat+pre_sodium_365days_cat+pre_potassium_365days_cat+pre_urine_proetein_ratio_365days_cat|group,data=matched_final)| control (N=840) |
case_no_vaccine (N=113) |
case_vaccine (N=727) |
Overall (N=1680) |
|
|---|---|---|---|---|
| Gender_Legal_Sex | ||||
| Female | 450 (53.6%) | 62 (54.9%) | 368 (50.6%) | 880 (52.4%) |
| Male | 390 (46.4%) | 51 (45.1%) | 359 (49.4%) | 800 (47.6%) |
| age_10year | ||||
| Mean (SD) | 7.34 (1.33) | 7.02 (1.57) | 7.37 (1.29) | 7.33 (1.33) |
| Median [Min, Max] | 7.50 [2.15, 10.0] | 7.30 [3.21, 9.88] | 7.52 [2.18, 10.4] | 7.50 [2.15, 10.4] |
| htn | ||||
| 0 | 130 (15.5%) | 27 (23.9%) | 101 (13.9%) | 258 (15.4%) |
| 1 | 710 (84.5%) | 86 (76.1%) | 626 (86.1%) | 1422 (84.6%) |
| dm | ||||
| 0 | 446 (53.1%) | 63 (55.8%) | 369 (50.8%) | 878 (52.3%) |
| 1 | 394 (46.9%) | 50 (44.2%) | 358 (49.2%) | 802 (47.7%) |
| cad | ||||
| 0 | 383 (45.6%) | 64 (56.6%) | 343 (47.2%) | 790 (47.0%) |
| 1 | 457 (54.4%) | 49 (43.4%) | 384 (52.8%) | 890 (53.0%) |
| chf | ||||
| 0 | 751 (89.4%) | 106 (93.8%) | 646 (88.9%) | 1503 (89.5%) |
| 1 | 89 (10.6%) | 7 (6.2%) | 81 (11.1%) | 177 (10.5%) |
| copd | ||||
| 0 | 689 (82.0%) | 104 (92.0%) | 593 (81.6%) | 1386 (82.5%) |
| 1 | 151 (18.0%) | 9 (8.0%) | 134 (18.4%) | 294 (17.5%) |
| nsaid | ||||
| 0 | 673 (80.1%) | 93 (82.3%) | 582 (80.1%) | 1348 (80.2%) |
| 1 | 167 (19.9%) | 20 (17.7%) | 145 (19.9%) | 332 (19.8%) |
| beta_blockers | ||||
| 0 | 495 (58.9%) | 70 (61.9%) | 413 (56.8%) | 978 (58.2%) |
| 1 | 345 (41.1%) | 43 (38.1%) | 314 (43.2%) | 702 (41.8%) |
| statins | ||||
| 0 | 424 (50.5%) | 75 (66.4%) | 345 (47.5%) | 844 (50.2%) |
| 1 | 416 (49.5%) | 38 (33.6%) | 382 (52.5%) | 836 (49.8%) |
| ace_arb | ||||
| 0 | 515 (61.3%) | 70 (61.9%) | 428 (58.9%) | 1013 (60.3%) |
| 1 | 325 (38.7%) | 43 (38.1%) | 299 (41.1%) | 667 (39.7%) |
| ppi | ||||
| 0 | 568 (67.6%) | 82 (72.6%) | 486 (66.9%) | 1136 (67.6%) |
| 1 | 272 (32.4%) | 31 (27.4%) | 241 (33.2%) | 544 (32.4%) |
| diur | ||||
| 0 | 530 (63.1%) | 76 (67.3%) | 448 (61.6%) | 1054 (62.7%) |
| 1 | 310 (36.9%) | 37 (32.7%) | 279 (38.4%) | 626 (37.3%) |
| immunosuppressant | ||||
| 0 | 792 (94.3%) | 106 (93.8%) | 690 (94.9%) | 1588 (94.5%) |
| 1 | 48 (5.7%) | 7 (6.2%) | 37 (5.1%) | 92 (5.5%) |
| vaccine_ACTUAL | ||||
| 0 | 126 (15.0%) | 113 (100%) | 0 (0%) | 239 (14.2%) |
| 1 | 714 (85.0%) | 0 (0%) | 727 (100%) | 1441 (85.8%) |
| renal_group2 | ||||
| eGFR <30, no ESKD | 58 (6.9%) | 4 (3.5%) | 50 (6.9%) | 112 (6.7%) |
| eGFR 30-44.9, no ESKD | 177 (21.1%) | 26 (23.0%) | 168 (23.1%) | 371 (22.1%) |
| eGFR 45-59.9, no ESKD | 506 (60.2%) | 70 (61.9%) | 428 (58.9%) | 1004 (59.8%) |
| ESKD | 99 (11.8%) | 13 (11.5%) | 81 (11.1%) | 193 (11.5%) |
| cancer | ||||
| 0 | 473 (56.3%) | 81 (71.7%) | 405 (55.7%) | 959 (57.1%) |
| 1 | 367 (43.7%) | 32 (28.3%) | 322 (44.3%) | 721 (42.9%) |
| pre_cre_freq_cat | ||||
| 1 | 181 (21.5%) | 17 (15.0%) | 159 (21.9%) | 357 (21.3%) |
| 2-4 | 659 (78.5%) | 96 (85.0%) | 568 (78.1%) | 1323 (78.8%) |
| pre_inpt_freq_cat | ||||
| 0 | 617 (73.5%) | 70 (61.9%) | 551 (75.8%) | 1238 (73.7%) |
| 1-2 | 124 (14.8%) | 24 (21.2%) | 94 (12.9%) | 242 (14.4%) |
| 3+ | 99 (11.8%) | 19 (16.8%) | 82 (11.3%) | 200 (11.9%) |
| new_renal_outcome_status | ||||
| Mean (SD) | 0.0595 (0.237) | 0.0531 (0.225) | 0.0316 (0.175) | 0.0470 (0.212) |
| Median [Min, Max] | 0 [0, 1.00] | 0 [0, 1.00] | 0 [0, 1.00] | 0 [0, 1.00] |
| new_dm_outcome_status | ||||
| Mean (SD) | 0.0310 (0.173) | 0.0177 (0.132) | 0.0206 (0.142) | 0.0256 (0.158) |
| Median [Min, Max] | 0 [0, 1.00] | 0 [0, 1.00] | 0 [0, 1.00] | 0 [0, 1.00] |
| new_cv_outcome_status | ||||
| Mean (SD) | 0.183 (0.387) | 0.212 (0.411) | 0.176 (0.381) | 0.182 (0.386) |
| Median [Min, Max] | 0 [0, 1.00] | 0 [0, 1.00] | 0 [0, 1.00] | 0 [0, 1.00] |
| sglt2i | ||||
| 0 | 801 (95.4%) | 105 (92.9%) | 686 (94.4%) | 1592 (94.8%) |
| 1 | 39 (4.6%) | 8 (7.1%) | 41 (5.6%) | 88 (5.2%) |
| ccb | ||||
| 0 | 582 (69.3%) | 80 (70.8%) | 500 (68.8%) | 1162 (69.2%) |
| 1 | 258 (30.7%) | 33 (29.2%) | 227 (31.2%) | 518 (30.8%) |
| pre_HGB_365days_cat | ||||
| Missing | 40 (4.8%) | 6 (5.3%) | 76 (10.5%) | 122 (7.3%) |
| Q1 | 200 (23.8%) | 29 (25.7%) | 163 (22.4%) | 392 (23.3%) |
| Q2 | 204 (24.3%) | 23 (20.4%) | 164 (22.6%) | 391 (23.3%) |
| Q3 | 174 (20.7%) | 22 (19.5%) | 167 (23.0%) | 363 (21.6%) |
| Q4 | 222 (26.4%) | 33 (29.2%) | 157 (21.6%) | 412 (24.5%) |
| pre_ALB_365days_cat | ||||
| Missing | 136 (16.2%) | 7 (6.2%) | 112 (15.4%) | 255 (15.2%) |
| Q1 | 162 (19.3%) | 56 (49.6%) | 205 (28.2%) | 423 (25.2%) |
| Q2 | 179 (21.3%) | 14 (12.4%) | 140 (19.3%) | 333 (19.8%) |
| Q3 | 212 (25.2%) | 20 (17.7%) | 163 (22.4%) | 395 (23.5%) |
| Q4 | 151 (18.0%) | 16 (14.2%) | 107 (14.7%) | 274 (16.3%) |
| pre_WBC_365days_cat | ||||
| Missing | 40 (4.8%) | 6 (5.3%) | 76 (10.5%) | 122 (7.3%) |
| Q1 | 191 (22.7%) | 47 (41.6%) | 186 (25.6%) | 424 (25.2%) |
| Q2 | 189 (22.5%) | 21 (18.6%) | 145 (19.9%) | 355 (21.1%) |
| Q3 | 209 (24.9%) | 14 (12.4%) | 153 (21.0%) | 376 (22.4%) |
| Q4 | 211 (25.1%) | 25 (22.1%) | 167 (23.0%) | 403 (24.0%) |
| pre_sodium_365days_cat | ||||
| Missing | 7 (0.8%) | 1 (0.9%) | 4 (0.6%) | 12 (0.7%) |
| Q1 | 237 (28.2%) | 49 (43.4%) | 244 (33.6%) | 530 (31.5%) |
| Q2 | 211 (25.1%) | 25 (22.1%) | 172 (23.7%) | 408 (24.3%) |
| Q3 | 221 (26.3%) | 26 (23.0%) | 179 (24.6%) | 426 (25.4%) |
| Q4 | 164 (19.5%) | 12 (10.6%) | 128 (17.6%) | 304 (18.1%) |
| pre_potassium_365days_cat | ||||
| Missing | 12 (1.4%) | 2 (1.8%) | 13 (1.8%) | 27 (1.6%) |
| Q1 | 224 (26.7%) | 41 (36.3%) | 193 (26.5%) | 458 (27.3%) |
| Q2 | 204 (24.3%) | 20 (17.7%) | 176 (24.2%) | 400 (23.8%) |
| Q3 | 198 (23.6%) | 27 (23.9%) | 182 (25.0%) | 407 (24.2%) |
| Q4 | 202 (24.0%) | 23 (20.4%) | 163 (22.4%) | 388 (23.1%) |
| pre_urine_proetein_ratio_365days_cat | ||||
| <=0.1 | 14 (1.7%) | 0 (0%) | 4 (0.6%) | 18 (1.1%) |
| >0.1 | 30 (3.6%) | 1 (0.9%) | 18 (2.5%) | 49 (2.9%) |
| Not checked | 796 (94.8%) | 112 (99.1%) | 705 (97.0%) | 1613 (96.0%) |
## Registered S3 method overwritten by 'gdata':
## method from
## reorder.factor DescTools##
##
## Cell Contents
## |-------------------------|
## | N |
## | Chi-square contribution |
## | N / Row Total |
## | N / Col Total |
## | N / Table Total |
## |-------------------------|
##
##
## Total Observations in Table: 1680
##
##
## | matched_final$group
## matched_final$hosp_outcome_30days_status | control | case_no_vaccine | case_vaccine | Row Total |
## -----------------------------------------|-----------------|-----------------|-----------------|-----------------|
## 0 | 759 | 100 | 664 | 1523 |
## | 0.008 | 0.058 | 0.037 | |
## | 0.498 | 0.066 | 0.436 | 0.907 |
## | 0.904 | 0.885 | 0.913 | |
## | 0.452 | 0.060 | 0.395 | |
## -----------------------------------------|-----------------|-----------------|-----------------|-----------------|
## 1 | 81 | 13 | 63 | 157 |
## | 0.080 | 0.564 | 0.359 | |
## | 0.516 | 0.083 | 0.401 | 0.093 |
## | 0.096 | 0.115 | 0.087 | |
## | 0.048 | 0.008 | 0.037 | |
## -----------------------------------------|-----------------|-----------------|-----------------|-----------------|
## Column Total | 840 | 113 | 727 | 1680 |
## | 0.500 | 0.067 | 0.433 | |
## -----------------------------------------|-----------------|-----------------|-----------------|-----------------|
##
## | Characteristic | N | HR1 | 95% CI1 | p-value |
|---|---|---|---|---|
| age_bl | 1,680 | 1.01 | 1.00, 1.03 | 0.080 |
| group | 1,680 | |||
| control | — | — | ||
| case_no_vaccine | 1.17 | 0.66, 2.08 | 0.590 | |
| case_vaccine | 0.88 | 0.63, 1.21 | 0.425 | |
| Gender_Legal_Sex | 1,680 | |||
| Female | — | — | ||
| Male | 1.03 | 0.75, 1.42 | 0.841 | |
| htn | 1,680 | |||
| 0 | — | — | ||
| 1 | 2.25 | 1.24, 4.06 | 0.007 | |
| dm | 1,680 | |||
| 0 | — | — | ||
| 1 | 1.45 | 1.07, 1.96 | 0.017 | |
| copd | 1,680 | |||
| 0 | — | — | ||
| 1 | 1.72 | 1.21, 2.45 | 0.003 | |
| cad | 1,680 | |||
| 0 | — | — | ||
| 1 | 1.79 | 1.29, 2.48 | <0.001 | |
| chf | 1,680 | |||
| 0 | — | — | ||
| 1 | 2.02 | 1.36, 3.00 | <0.001 | |
| subclass | 1,680 | 1.00 | 1.00, 1.00 | 0.182 |
| 1 HR = Hazard Ratio, CI = Confidence Interval | ||||
| Characteristic | N | HR1 | 95% CI1 | p-value |
|---|---|---|---|---|
| age_bl | 1,680 | 1.01 | 0.99, 1.02 | 0.357 |
| group | 1,680 | |||
| control | — | — | ||
| case_no_vaccine | 1.35 | 0.76, 2.40 | 0.313 | |
| case_vaccine | 0.86 | 0.62, 1.19 | 0.361 | |
| Gender_Legal_Sex | 1,680 | |||
| Female | — | — | ||
| Male | 1.01 | 0.73, 1.39 | 0.968 | |
| htn | 1,680 | |||
| 0 | — | — | ||
| 1 | 1.61 | 0.88, 2.97 | 0.124 | |
| dm | 1,680 | |||
| 0 | — | — | ||
| 1 | 1.17 | 0.84, 1.63 | 0.347 | |
| copd | 1,680 | |||
| 0 | — | — | ||
| 1 | 1.39 | 0.96, 2.03 | 0.084 | |
| cad | 1,680 | |||
| 0 | — | — | ||
| 1 | 1.37 | 0.96, 1.96 | 0.083 | |
| chf | 1,680 | |||
| 0 | — | — | ||
| 1 | 1.50 | 0.97, 2.33 | 0.068 | |
| 1 HR = Hazard Ratio, CI = Confidence Interval | ||||
| Characteristic | N | HR1 | 95% CI1 | p-value |
|---|---|---|---|---|
| age_bl | 1,680 | 1.07 | 1.02, 1.11 | 0.005 |
| group | 1,680 | |||
| control | — | — | ||
| case_no_vaccine | 18.5 | 6.53, 52.6 | <0.001 | |
| case_vaccine | 2.79 | 0.98, 7.96 | 0.056 | |
| Gender_Legal_Sex | 1,680 | |||
| Female | — | — | ||
| Male | 1.18 | 0.57, 2.45 | 0.657 | |
| htn | 1,680 | |||
| 0 | — | — | ||
| 1 | 0.57 | 0.24, 1.32 | 0.187 | |
| dm | 1,680 | |||
| 0 | — | — | ||
| 1 | 0.67 | 0.32, 1.40 | 0.286 | |
| cad | 1,680 | |||
| 0 | — | — | ||
| 1 | 1.26 | 0.60, 2.63 | 0.538 | |
| chf | 1,680 | |||
| 0 | — | — | ||
| 1 | 0.63 | 0.15, 2.66 | 0.529 | |
| copd | 1,680 | |||
| 0 | — | — | ||
| 1 | 2.13 | 0.97, 4.66 | 0.059 | |
| subclass | 1,680 | 1.00 | 1.00, 1.00 | 0.059 |
| 1 HR = Hazard Ratio, CI = Confidence Interval | ||||
| Characteristic | N | HR1 | 95% CI1 | p-value |
|---|---|---|---|---|
| age_bl | 1,680 | 1.07 | 1.02, 1.11 | 0.002 |
| group | 1,680 | |||
| control | — | — | ||
| case_no_vaccine | 22.7 | 8.07, 64.0 | <0.001 | |
| case_vaccine | 2.86 | 1.01, 8.09 | 0.048 | |
| Gender_Legal_Sex | 1,680 | |||
| Female | — | — | ||
| Male | 1.23 | 0.57, 2.64 | 0.602 | |
| htn | 1,680 | |||
| 0 | — | — | ||
| 1 | 0.42 | 0.19, 0.95 | 0.038 | |
| dm | 1,680 | |||
| 0 | — | — | ||
| 1 | 0.69 | 0.29, 1.59 | 0.380 | |
| copd | 1,680 | |||
| 0 | — | — | ||
| 1 | 2.69 | 1.14, 6.38 | 0.024 | |
| cad | 1,680 | |||
| 0 | — | — | ||
| 1 | 1.65 | 0.82, 3.31 | 0.159 | |
| chf | 1,680 | |||
| 0 | — | — | ||
| 1 | 0.53 | 0.11, 2.51 | 0.422 | |
| 1 HR = Hazard Ratio, CI = Confidence Interval | ||||
##
##
## Cell Contents
## |-------------------------|
## | N |
## | Chi-square contribution |
## | N / Row Total |
## | N / Col Total |
## | N / Table Total |
## |-------------------------|
##
##
## Total Observations in Table: 75
##
##
## | matched_final$group
## matched_final$Critical_illness_30days | control | case_no_vaccine | case_vaccine | Row Total |
## --------------------------------------|-----------------|-----------------|-----------------|-----------------|
## 0 | 0 | 10 | 53 | 63 |
## | NaN | 0.078 | 0.016 | |
## | 0.000 | 0.159 | 0.841 | 0.840 |
## | NaN | 0.769 | 0.855 | |
## | 0.000 | 0.133 | 0.707 | |
## --------------------------------------|-----------------|-----------------|-----------------|-----------------|
## 1 | 0 | 3 | 9 | 12 |
## | NaN | 0.407 | 0.085 | |
## | 0.000 | 0.250 | 0.750 | 0.160 |
## | NaN | 0.231 | 0.145 | |
## | 0.000 | 0.040 | 0.120 | |
## --------------------------------------|-----------------|-----------------|-----------------|-----------------|
## Column Total | 0 | 13 | 62 | 75 |
## | 0.000 | 0.173 | 0.827 | |
## --------------------------------------|-----------------|-----------------|-----------------|-----------------|
##
## | Characteristic | N | OR1 | 95% CI1 | p-value |
|---|---|---|---|---|
| age_bl | 75 | 1.03 | 0.97, 1.09 | 0.389 |
| vaccine_ACTUAL | 75 | |||
| 0 | — | — | ||
| 1 | 0.57 | 0.14, 2.88 | 0.448 | |
| Gender_Legal_Sex | 75 | |||
| Female | — | — | ||
| Male | 1.03 | 0.29, 3.63 | 0.960 | |
| htn | 75 | |||
| 0 | — | — | ||
| 1 | 0.25 | 0.04, 2.07 | 0.155 | |
| dm | 75 | |||
| 0 | — | — | ||
| 1 | 0.66 | 0.19, 2.32 | 0.508 | |
| cad | 75 | |||
| 0 | — | — | ||
| 1 | 0.81 | 0.23, 2.99 | 0.735 | |
| chf | 75 | |||
| 0 | — | — | ||
| 1 | 1.20 | 0.17, 5.60 | 0.831 | |
| copd | 75 | |||
| 0 | — | — | ||
| 1 | 0.98 | 0.20, 3.77 | 0.977 | |
| 1 OR = Odds Ratio, CI = Confidence Interval | ||||
| Characteristic | N | OR1 | 95% CI1 | p-value |
|---|---|---|---|---|
| age_bl | 75 | 1.05 | 0.99, 1.12 | 0.122 |
| vaccine_ACTUAL | 75 | |||
| 0 | — | — | ||
| 1 | 0.48 | 0.08, 3.08 | 0.407 | |
| Gender_Legal_Sex | 75 | |||
| Female | — | — | ||
| Male | 1.28 | 0.30, 5.80 | 0.741 | |
| htn | 75 | |||
| 0 | — | — | ||
| 1 | 0.12 | 0.01, 1.45 | 0.084 | |
| dm | 75 | |||
| 0 | — | — | ||
| 1 | 0.76 | 0.20, 2.91 | 0.685 | |
| cad | 75 | |||
| 0 | — | — | ||
| 1 | 0.74 | 0.16, 3.64 | 0.706 | |
| chf | 75 | |||
| 0 | — | — | ||
| 1 | 2.13 | 0.26, 13.3 | 0.432 | |
| copd | 75 | |||
| 0 | — | — | ||
| 1 | 1.21 | 0.22, 5.56 | 0.813 | |
| 1 OR = Odds Ratio, CI = Confidence Interval | ||||